Cervical Adenocarcinoma
About
Mappings
NCI Thesaurus: Cervical Adenocarcinoma (coding:ncit:C4029)
OncoTree: Cervical Adenocarcinoma (coding:oncotree:CEAD)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Adenocarcinoma | Cisplatin, Paclitaxel, Pembrolizumab | |
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Adenocarcinoma | Bevacizumab, Cisplatin, Paclitaxel, Pembrolizumab | |
| EMA (1) FDA (2) | PD-L1 (CPS) >= 1 | Cervical Adenocarcinoma | Carboplatin, Paclitaxel, Pembrolizumab | |
| EMA (1) FDA (2) | PD-L1 (CPS) >= 1 | Cervical Adenocarcinoma | Bevacizumab, Carboplatin, Paclitaxel, Pembrolizumab | |
| FDA (2) | PD-L1 (CPS) >= 1 | Cervical Adenocarcinoma | Pembrolizumab |